|
Arrhythmia Research Technology, Inc. (AMEX: HRT) announced that its wholly owned subsidiary Micron Products
Inc. (“Micron”), has entered into a three-year supply agreement with the Molecular Diagnostics division of Osmetech
plc (LSE: OMH). Micron, through its New England Molders division (“NEM”), will provide manufacturing services for
consumables components used in Osmetech’s OPTI TUBE™ and OPTI GENE™ product lines.
The OPTI TUBE™ product line consists of patented plastic tubes with ergonomic sealing caps and carousel which have
been designed as a replacement for the glass capillaries which are used in the Roche LightCycler®. OPTI TUBE™ is a
robust alternative solution with excellent optical and thermal properties that eliminates the dangers of glass breakage and
minimizes the risk of laboratory personnel exposure to potentially dangerous samples and glass shards. The OPTI
TUBE™, developed from combined efforts by Osmetech and NEM engineers, have resulted in a cost effective
alternative to glass.
Osmetech’s OPTI GENE™ instrument is specifically designed to meet the requirements of the molecular diagnostic
market in the small to medium sized hospital. This product is designed to enable simple and more complex molecular
diagnostic tests to be performed accurately in a cost effective and easy to use format and meet the increasing demand for
genetic tests to improve disease management.
James E. Rouse, President and CEO of Arrhythmia Research Technology, Inc., commented, “We are very pleased to
have been chosen by Osmetech as the manufacturer of its disposables for the OPTI TUBE™ and OPTI GENE™ product
lines This agreement has significant long term benefits to both Micron and Osmetech. The opportunity to support a
company such as Osmetech as it grows into a leading player in the field of molecular diagnostics is a great opportunity
for our NEM division and the company as a whole, and will be the first of many products to be manufactured in our new
class 100,000 clean room. The close working relationship between the two companies will continue as we strive to
expand the scope of our supply agreement to additional product groups and value added services. The agreement
demonstrates the establishment of a mutually beneficial customer /supplier relationship. Micron's expansion into test
products for the molecular diagnostics industry complements the current line of high quality medical products we
manufacture."
James White, CEO of Osmetech said, “We are excited to be working with Micron Products. Micron’s customer focus
and commitment to quality made for an easy decision in the selection of Micron as our partner for the manufacture of
our molecular diagnostic disposables. The OPTI TUBE™ product has recently been launched and has demonstrated
excellent performance in comparative studies between the Roche glass capillaries and our plastic tubes.”
 Click here to see the full annoucement
|
